Log in to save to my catalogue

Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multir...

Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multir...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_91f0f017bd784a0087174f5750d3561a

Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria

About this item

Full title

Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-09, Vol.12 (1), p.16001-16001, Article 16001

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Patients infected with SARS-CoV-2 risk co-infection with Gram-positive bacteria, which severely affects their prognosis. Antimicrobial drugs with dual antiviral and antibacterial activity would be very useful in this setting. Although glycopeptide antibiotics are well-known as strong antibacterial drugs, some of them are also active against RNA vir...

Alternative Titles

Full title

Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_91f0f017bd784a0087174f5750d3561a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_91f0f017bd784a0087174f5750d3561a

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-20182-y

How to access this item